As shown in Figure 3, in adrenocortical carcinoma (ACC), patients with high CHST4 expression had longer overall survival (OS) and disease-free survival (DFS) than those with low CHST4 expression. This evidence concerns the gene CHST4 and adrenal cortex carcinoma.